Page 4 - Mike Beyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Blue Earth Therapeutics Announces Publication of Results from Independent Clinical Experience with 1

– First reported clinical results from independent clinical experience by University of Augsburg demonstrated encouraging preliminary data for 177Lu-rhPSMA-10.1 –– 177Lutetium-labeled radiohybrid (rh) Prostate-Specific Membrane Antigen (177Lu-rhPSMA-10.1) is now in clinical development as a highly optimized, next ge.

United kingdomUnited statesMike beyerPriscilla harlanDavid gaudenClare gidleyConstantin lapaUniversity hospital augsburgCorporate communicationsUniversity hospitalUniversity of augsburgDepartment of nuclear medicineBracco groupJournal of nuclear medicineDrug administrationSam brown inc

Passage Bio To Present At Guggenheim Healthcare Talks 6Th Annual Biotechnology Conference

Passage Bio To Present At Guggenheim Healthcare Talks 6Th Annual Biotechnology Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesMike beyerWilliam chouMadeline nafusPassage bio incSam brown incGuggenheim healthcare talksAnnual biotechnology conferencePassage bioBio investorsBio media

Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

PHILADELPHIA, Jan. 31, 2024 (GLOBE NEWSWIRE) Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that

United statesMike beyerWilliam chouMadeline nafusPassage bio incSam brown incHealthcare communicationsGuggenheim healthcare talksAnnual biotechnology conferencePassage bioBio investorsBio media

Blue Earth Diagnostics Highlights Clinical Utility of POSLUMA (Flotufolastat F 18) PET and Post-scan Changes in Management in Patients with Suspected Recurrence of Prostate Cancer at ASCO GU

Blue Earth Diagnostics Highlights Clinical Utility of POSLUMA (Flotufolastat F 18) PET and Post-scan Changes in Management in Patients with Suspected Recurrence of Prostate Cancer at ASCO GU
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomClare gidleySanta monicaDavide gaudenStefan klotterPriscilla harlanScintomics gmbPrzemyslaw twardowskiMike beyerCompany phaseNuclear medicineSam brown incStudy groupA siemens healthineers companyCorporate communicationsTechnical university of munich

MiNA Therapeutics Limited: MiNA Therapeutics Presents New Data for its HbF Program at the Keystone Symposia s Delivery of Nucleic Acid Therapeutics Conference

MiNA Therapeutics Limited: MiNA Therapeutics Presents New Data for its HbF Program at the Keystone Symposia s Delivery of Nucleic Acid Therapeutics Conference
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Stefan klotterRobert habibMike beyerSam brown incMina therapeuticsKeystone symposiaNucleic acid therapeutics conferenceErythroid progenitor cellsDie performance strategieAssets sie